Logos Global Management »

Ionis Pharmaceuticals shares owned by Logos Global Management

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Logos Global Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 300k 47.66

More positions owned by Logos Global Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Sarepta Therapeutics (SRPT)
Sarepta Therapeutics Call Option (SRPT)
Apellis Pharmaceuticals Call Option (APLS)
Apellis Pharmaceuticals (APLS)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Structure Therapeutics Sponsored Ads (GPCR)
Ideaya Biosciences (IDYA)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Argenx Se Sponsored Adr (ARGX)
Merus N V (MRUS)
Merus N V (MRUS)
Revolution Medicines (RVMD)

View all positions for Logos Global Management

Top funds holding Ionis Pharmaceuticals

T. Rowe Price Investment Management
Vanguard Group
BlackRock
BlackRock
Bellevue Group
Capital World Investors
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
OrbiMed Advisors
Artisan Partners Limited Partnership
Deep Track Capital
Marshall Wace
Macquarie Group
ClearBridge Advisors

View all funds holding Ionis Pharmaceuticals